Myositis launch for $XGN will be a big commercial inflection, me thinks. But notice what the good doctor also says?
$LH and $DGX currently capture volumes because where $XGN lacks markers, but what happens as $XGN platform grows? Likely a buyout.
Won’t happen, I’m usually
